In the investigation of the side effects of incretin-based drugs, several observational studies showed that the use of incretin-based drugs was associated with an increased risk of some cancer types, such as pancreatic cancer [13], breast cancer [125], and thyroid cancer [12, 126]. This evidence concerns the gene GCG and breast carcinoma.